Science Explorer Back to mapMap

Pericarditis and Cardiac Tamponade

Pericarditis and Cardiac Tamponade is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 16k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and management of pericardial diseases, including pericarditis, constrictive pericarditis, and tuberculous pericarditis. It explores the use of colchicine therapy, echocardiography, and cardiac magnetic resonance imaging in the evaluation and treatment of these conditions.

  • Pericarditis
  • Constrictive Pericarditis
  • Colchicine Therapy
  • Echocardiography
  • Cardiac Tamponade
  • Multimodality Imaging
  • Tuberculous Pericarditis
  • Pericardiectomy
  • Recurrent Pericarditis
  • Cardiac Magnetic Resonance Imaging
Research works
16k
fractional, since 1950
In the world top 10%
1.6k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+28%
the tick is no change
Largest producer
United States
44% of the 10 largest, 2022-now
Pericarditis and Cardiac Tamponade

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Pericarditis and Cardiac Tamponade research?

By volume, the United States and China publish the most (1.3k and 369 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.3k works
  2. 2 China 369 works
  3. 3 Japan 263 works
  4. 4 Italy 225 works
  5. 5 India 190 works
  6. 6 United Kingdom 149 works
  7. 7 Germany 141 works
  8. 8 Spain 125 works
  9. 9 Türkiye 92 works
  10. 10 France 72 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 44.5%China: 12.6%Japan: 9.0%Italy: 7.7%6 others listed: 26.3%44%largest
United States1,301 · 44.5%China369 · 12.6%Japan263 · 9.0%Italy225 · 7.7%6 others listed768 · 26.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Pericarditis and Cardiac Tamponade research?

By volume in 2022-now, Cleveland Clinic publishes the most Pericarditis and Cardiac Tamponade research, followed by Mayo Clinic and All India Institute of Medical Sciences.

Who are the leading researchers in Pericarditis and Cardiac Tamponade?

The most-cited researchers publishing on Pericarditis and Cardiac Tamponade include John J.V. McMurray, Emelia J. Benjamin and Stephan Windecker.

  1. 1 John J.V. McMurray United Kingdom 349k citations
  2. 2 Emelia J. Benjamin United States 341k citations
  3. 3 Stephan Windecker Switzerland 338k citations
  4. 4 Gregory Y.H. Lip United Kingdom 311k citations
  5. 5 Salim Yusuf Canada 294k citations
  6. 6 Victoria Delgado Netherlands 269k citations
  7. 7 Jean‐Louis Vincent Belgium 262k citations
  8. 8 Valentı́n Fuster United States 257k citations
  9. 9 Patrizio Lancellotti Belgium 245k citations
  10. 10 Daniel Levy United States 245k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Pericarditis and Cardiac Tamponade?

The most cited paper in Pericarditis and Cardiac Tamponade is "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases" (Alida L.P. Caforio et al., 2013), with 3,492 citations. Next come "Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction" (3,135) and "2015 ESC Guidelines for the diagnosis and management of pericardial diseases" (2,643).

Most cited papers
#PaperReleasedCitations
1 Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Alida L.P. Caforio et al. · European Heart Journal Open access 3 Jul 2013 3,492
2 Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction Jean‐Claude Tardif et al. · New England Journal of Medicine Open access 16 Nov 2019 3,135
3 2015 ESC Guidelines for the diagnosis and management of pericardial diseases Yehuda Adler et al. · European Heart Journal Open access118 authors 29 Aug 2015 2,643
4 Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper Matthias G. Friedrich, Udo P Sechtem, Jeanette Schulz‐Menger et al. · Journal of the American College of Cardiology Open access Apr 2009 2,526
5 Colchicine in Patients with Chronic Coronary Disease Stefan Mark Nidorf et al. · New England Journal of Medicine Open access 31 Aug 2020 2,252
All 100 most cited papers, with filters and sorting

Where is Pericarditis and Cardiac Tamponade research done?

The largest centres of Pericarditis and Cardiac Tamponade research in 2022-now are Cleveland (United States), New York (United States), Tokyo (Japan) and Beijing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Cleveland.

Largest cities, 2022-now

  1. 1 ClevelandUnited States 81 works
  2. 2 New YorkUnited States 63 works
  3. 3 TokyoJapan 54 works
  4. 4 BeijingChina 54 works
  5. 5 LondonUnited Kingdom 49 works
  6. 6 MadridSpain 37 works
  7. 7 PhiladelphiaUnited States 36 works
  8. 8 RomeItaly 36 works
  9. 9 New DelhiIndia 34 works
  10. 10 MilanItaly 33 works

Where it is the local speciality

  1. ClevelandUS · 80.9 works14×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Pericarditis and Cardiac Tamponade than the world average.

See Pericarditis and Cardiac Tamponade on the map

Where is the best place to study Pericarditis and Cardiac Tamponade?

Among universities, judged by research, University of Udine, Harvard University and Johns Hopkins University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 17.08%fractional works in this field (log) →share of work in the world top 10% →University of UdineJohns Hopkins Univer…Northwestern Univers…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of UdineItaly 76.242.7%23.3×13 +198.4%
2Harvard UniversityUnited States 61.913.0%2.5×28 +7.3%
3Johns Hopkins UniversityUnited States 58.225.8%2.6×14 +76.4%
4Northwestern UniversityUnited States 50.518.8%5.0×15 +52.0%
5All India Institute of Medical SciencesIndia 49.41.2%7.9×31 +53.1%
6Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 48.119.3%3.9×14 +54.7%
7Università Cattolica del Sacro CuoreItaly 46.115.8%7.1×11 +269.8%
8Case Western Reserve UniversityUnited States 44.814.8%5.8×12 +113.3%
9University of California, Los AngelesUnited States 43.26.1%4.0×16 +79.6%
10University of PaduaItaly 41.813.3%3.3×9 +29.7%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Pericarditis and Cardiac Tamponade, country by country

Is Pericarditis and Cardiac Tamponade research growing?

Output in 2022-2025 was 28% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Pericarditis and Cardiac Tamponade.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pericarditis and Cardiac Tamponade as a percentage of every work published that year, 0.014% in 2024.

still counting0.010%0.020%0.030%Pericarditis and Cardiac Tamponade0.017% in 202519801990200020102020

Fractional works of Pericarditis and Cardiac Tamponade over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Pericarditis and Cardiac Tamponade10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Pericarditis and Cardiac Tamponade. Posts are plain text and can be reported.